Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
9.61
+0.29 (3.11%)
At close: Dec 20, 2024, 4:00 PM
9.66
+0.05 (0.52%)
After-hours: Dec 20, 2024, 7:58 PM EST
Cybin Market Cap
Cybin has a market cap or net worth of $192.21 million as of December 20, 2024. Its market cap has increased by 12.62% in one year.
Market Cap
192.21M
Enterprise Value
78.08M
1-Year Change
12.62%
Ranking
Category
Stock Price
$9.61
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $192.21M, an increase of 111.00%. That is a compound annual growth rate of 19.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 192.21M | 13.99% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 198.65M |
| Organigram Holdings | 197.95M |
| Mersana Therapeutics | 197.65M |
| XBiotech | 194.48M |
| Perspective Therapeutics | 192.62M |
| Inozyme Pharma | 192.08M |
| Fate Therapeutics | 191.34M |
| Gossamer Bio | 190.35M |